Alyeska Investment Group, L.P. Tandem Diabetes Care Inc Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $968,177 - $2.21 Million	30,021 Added 150.11%	50,021 $0
Q3 2018 Nov 14, 2018	SELL	$21.39 - $51.17 $2.55 Million - $6.1 Million	-119,196 Reduced 85.63%	20,000 $857,000
Q4 2017 Feb 14, 2018	BUY	$2.24 - $8.2 $311,799 - $1.14 Million	139,196	139,196 $329,000

351

73M

3.12M

343K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.1B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.